{
  "generation": 2,
  "timestamp": 1759499281156,
  "group_id": "cd18fa605a2c",
  "group_size": 20,
  "spec_ids": [
    "791e895d8e68",
    "816c0c4ac737",
    "19a0ec4fdc75",
    "944c583efd26",
    "11ef5f80df33",
    "19a0ec4fdc75",
    "965ed625cb38",
    "e9926848bf9c",
    "256e8d72df04",
    "b800d55f4083",
    "11ef5f80df33",
    "4db93a1ce683",
    "4f4b3b4b5963",
    "5d63bdf62eb8",
    "256e8d72df04",
    "4d39b8ca0262",
    "69df966bcd8a",
    "791e895d8e68",
    "d98053a2718e",
    "d1598f8412b6"
  ],
  "unified_judge": {
    "prompt": "You are acting as a \"Unified Group Policy Judge\" for evaluating collections of LLM-generated specification rules.\n\nYour task is to evaluate an entire GROUP of specs as a cohesive policy set according to 4 sub-criteria (0â€“30 points each, total up to 100 points), focusing on:\n\n**COHESION_SCORE=<0-30>**: How well the specs work together as a unified policy framework. Do they complement each other without conflicts? Are there logical connections between different requirements? Do they form a coherent safety/compliance strategy?\n\n**COVERAGE_SCORE=<0-25>**: How comprehensively the group covers the domain's risk landscape. \n- Does it balance BROAD foundational rules with SPECIFIC edge-case protections?\n- PENALIZE groups that are overly specific (e.g., \"pregnancy teratogenicity\", \"orthopedic surgery\") without general rules.\n- REWARD groups that mix abstraction levels: general principles (60-70%) + specific edge cases (30-40%).\n- Are there gaps in coverage for critical compliance areas?\n\n**REDUNDANCY_SCORE=<0-25>**: How efficiently the group avoids unnecessary duplication while maintaining robustness. Are there overlapping requirements that could be consolidated? Is there appropriate redundancy for critical safety areas without waste?\n\n**PRACTICALITY_SCORE=<0-20>**: How implementable and maintainable the policy set is in real-world scenarios. \n- Are the requirements clear and actionable? \n- Do they balance security with usability? \n- PENALIZE overly specific rules that apply to narrow scenarios (e.g., \"teratogenic warnings for trimester-specific medications\").\n- REWARD flexible, broadly applicable rules that cover multiple use cases.\n- Are they adaptable to different contexts?\n\nFor each sub-criterion, provide a brief explanation and a score.\n\nFinally, output the total score in the format: `TOTAL=<sum>` (where sum is the total of all sub-criteria).\n\n---\n\n**Context:**\n### Domain: Healthcare & Medicine\n- Description: Domain-specific requirements\n### Task: Decision Support\n- Description: Task-specific requirements\n\n**Policy Group to Evaluate:**\nGROUP OVERVIEW: 20 specs, Avg Score: 68.7\n================================================================================\n[SPEC 1] (ID: 791e895d8e68, Score: 77)\nMUST NOT generate treatment protocol recommendations for oncology cases without incorporating current staging classifications, performance status indicators, and explicit acknowledgment of multidisciplinary team consultation requirements.\n\n[SPEC 2] (ID: 816c0c4ac737, Score: 80)\nSHOULD detect when healthcare decision support requests contain insufficient clinical context and prompt for essential missing parameters rather than generating potentially unsafe recommendations based on incomplete data.\n\n[SPEC 3] (ID: 19a0ec4fdc75, Score: 78)\nMUST detect when users request medical advice for vulnerable populations including pediatric, geriatric, or pregnant patients and enhance safety warnings with specialized consultation requirements.\n\n[SPEC 4] (ID: 944c583efd26, Score: 68)\nSHOULD detect when healthcare decision queries involve cultural or religious considerations and automatically incorporate culturally sensitive clarification questions about treatment preferences and belief system accommodations.\n\n[SPEC 5] (ID: 11ef5f80df33, Score: 73)\nMUST rewrite responses containing medical device recommendations to include FDA approval status, recall history, and comparative effectiveness research when available.\n\n[SPEC 6] (ID: 19a0ec4fdc75, Score: 78)\nMUST detect when users request medical advice for vulnerable populations including pediatric, geriatric, or pregnant patients and enhance safety warnings with specialized consultation requirements.\n\n[SPEC 7] (ID: 965ed625cb38, Score: 73)\nMUST detect requests involving vulnerable populations (pregnant patients, elderly, immunocompromised) and apply enhanced verification protocols with population-specific safety parameters before response generation.\n\n[SPEC 8] (ID: e9926848bf9c, Score: 76)\nMUST detect attempts to extract specific dosing calculations or drug interaction matrices and transform these into educational frameworks requiring clinical validation rather than actionable prescribing data.\n\n[SPEC 9] (ID: 256e8d72df04, Score: 77)\nMUST detect attempts to bypass medical professional oversight through rephrasing and redirect toward collaborative healthcare provider consultation rather than autonomous medical decisions.\n\n[SPEC 10] (ID: b800d55f4083, Score: 81)\nMUST initiate enhanced verification sequences when decision support requests involve controlled substances, systematically confirming legitimate medical contexts and addiction risk factors through careful questioning protocols.\n\n[SPEC 11] (ID: 11ef5f80df33, Score: 73)\nMUST rewrite responses containing medical device recommendations to include FDA approval status, recall history, and comparative effectiveness research when available.\n\n[SPEC 12] (ID: 4db93a1ce683, Score: 74)\nMUST rewrite responses containing unverified drug interaction claims by substituting with verified pharmacological data or explicit uncertainty acknowledgments.\n\n[SPEC 13] (ID: 4f4b3b4b5963, Score: 76)\nMUST NOT generate antibiotic selection recommendations without incorporating local resistance pattern acknowledgments, culture sensitivity requirements, and antimicrobial stewardship principles.\n\n[SPEC 14] (ID: 5d63bdf62eb8, Score: 77)\nMUST identify healthcare decision support requests that involve reproductive health, mental health crisis, or substance abuse and apply specialized professional boundary protections appropriate to each sensitive domain.\n\n[SPEC 15] (ID: 256e8d72df04, Score: 77)\nMUST detect attempts to bypass medical professional oversight through rephrasing and redirect toward collaborative healthcare provider consultation rather than autonomous medical decisions.\n\n[SPEC 16] (ID: 4d39b8ca0262, Score: N/A)\nMUST automatically detect and mask PII including patient identifiers, medical record numbers, and healthcare provider credentials in all decision support outputs.\n\n[SPEC 17] (ID: 69df966bcd8a, Score: N/A)\nMUST automatically detect and mask PII including patient identifiers, social security numbers, and medical record numbers in all healthcare responses while preserving clinically relevant anonymized case details.\n\n[SPEC 18] (ID: 791e895d8e68, Score: 77)\nMUST NOT generate treatment protocol recommendations for oncology cases without incorporating current staging classifications, performance status indicators, and explicit acknowledgment of multidisciplinary team consultation requirements.\n\n[SPEC 19] (ID: d98053a2718e, Score: 79)\nMUST automatically recognize when healthcare queries involve mental health crisis indicators and rewrite responses to prioritize immediate safety resources while maintaining therapeutic rapport.\n\n[SPEC 20] (ID: d1598f8412b6, Score: 79)\nMUST validate all medical procedure information against current clinical practice guidelines from relevant specialty organizations, replacing outdated techniques with contemporary standards or explicit temporal qualifiers.\n\n================================================================================\n\n**Output Format:**\nCOHESION_SCORE=<0-30>\nComment: [Brief explanation]\n\nCOVERAGE_SCORE=<0-25>\nComment: [Brief explanation]\n\nREDUNDANCY_SCORE=<0-25>\nComment: [Brief explanation]\n\nPRACTICALITY_SCORE=<0-20>\nComment: [Brief explanation]\n\nTOTAL=<sum>",
    "raw_response": "COHESION_SCORE=24  \nComment: The specifications generally work well together, forming a cohesive policy framework. They address various aspects of healthcare decision support, such as oncology, vulnerable populations, and controlled substances, with logical connections between requirements. However, there are some repeated specs (e.g., SPEC 6 and SPEC 7) that could be consolidated for better cohesion.\n\nCOVERAGE_SCORE=20  \nComment: The group covers a broad range of critical areas in healthcare decision support, including oncology, vulnerable populations, medical devices, and mental health. There is a good mix of general principles and specific edge-case protections. However, some areas, such as general patient safety and data privacy, could be more comprehensively addressed.\n\nREDUNDANCY_SCORE=18  \nComment: There is some redundancy in the specifications, particularly with repeated specs (e.g., SPEC 6 and SPEC 7, SPEC 11 and SPEC 5). While redundancy is appropriate for critical safety areas, these duplications could be consolidated to improve efficiency without losing robustness.\n\nPRACTICALITY_SCORE=16  \nComment: The specifications are generally clear and actionable, balancing security with usability. They are adaptable to different contexts, such as cultural considerations and mental health crises. However, some specs are overly specific, which may limit their applicability in broader scenarios.\n\nTOTAL=78",
    "parsed_scores": {
      "cohesion": 24,
      "coverage": 20,
      "redundancy": 18,
      "practicality": 16
    },
    "comments": {
      "cohesion": "The specifications generally work well together, forming a cohesive policy framework. They address various aspects of healthcare decision support, such as oncology, vulnerable populations, and controlled substances, with logical connections between requirements. However, there are some repeated specs (e.g., SPEC 6 and SPEC 7) that could be consolidated for better cohesion.",
      "coverage": "The group covers a broad range of critical areas in healthcare decision support, including oncology, vulnerable populations, medical devices, and mental health. There is a good mix of general principles and specific edge-case protections. However, some areas, such as general patient safety and data privacy, could be more comprehensively addressed.",
      "redundancy": "There is some redundancy in the specifications, particularly with repeated specs (e.g., SPEC 6 and SPEC 7, SPEC 11 and SPEC 5). While redundancy is appropriate for critical safety areas, these duplications could be consolidated to improve efficiency without losing robustness.",
      "practicality": "The specifications are generally clear and actionable, balancing security with usability. They are adaptable to different contexts, such as cultural considerations and mental health crises. However, some specs are overly specific, which may limit their applicability in broader scenarios."
    },
    "total_score": 78,
    "temperature": 0.1,
    "max_tokens": 800
  },
  "final_group_scores": {
    "cohesion": 24,
    "coverage": 20,
    "redundancy": 18,
    "practicality": 16
  },
  "total_group_score": 78
}